Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase ...
Q1 2026
May 11, 2026
FY 2025
Mar 3, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 11, 2025